{"transactions":[{"id":695460,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-06T00:45:46.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Rocket Pharmaceuticals, Inc. (the \"Company\") entered into a consulting agreement with the Reporting Person, dated July 21, 2026, for consulting services related to the Company's strategic and financial activities. As compensation for services rendered, the Reporting Person received 150,000 restricted stock units (\"RSUs\") on August 3, 2026."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Rocket Pharmaceuticals, Inc. (the \"Company\") entered into a consulting agreement with the Reporting Person, dated July 21, 2026, for consulting services related to the Company's strategic and financial activities. As compensation for services rendered, the Reporting Person received 150,000 restricted stock units (\"RSUs\") on August 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that convert to common stock on a one-for-one basis. One-third of such RSUs will vest in full on August 3, 2027, with the remaining two-thirds vesting in equal quarterly installments over the following two years."}],"balance_after":204522,"source":{"system":"sec-edgar","filing":"0001140361-26-031471","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126031471/form4.xml","form_type":"4"}},{"id":714882,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-06T23:59:56.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":64860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027."}],"balance_after":64860,"derivative":{"exercise_price":3.35,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":64860},"source":{"system":"sec-edgar","filing":"0001140361-26-027677","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126027677/form4.xml","form_type":"4"}},{"id":714881,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-06T23:59:56.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":22862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027."}],"balance_after":54522,"source":{"system":"sec-edgar","filing":"0001140361-26-027677","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126027677/form4.xml","form_type":"4"}},{"id":947921,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:20:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026."}],"balance_after":3475,"derivative":{"exercise_price":76.74,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":3475},"source":{"system":"sec-edgar","filing":"0001251553-26-000002","document":"form4-01062026_050112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000125155326000002/form4-01062026_050112.xml","form_type":"4"}},{"id":947920,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:20:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death."}],"balance_after":20850,"source":{"system":"sec-edgar","filing":"0001251553-26-000002","document":"form4-01062026_050112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000125155326000002/form4-01062026_050112.xml","form_type":"4"}},{"id":1043221,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T20:30:15.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":30.86,"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001415889-25-024280","document":"form4-09112025_040902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925024280/form4-09112025_040902.xml","form_type":"4"}},{"id":1043220,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:30:15.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":58.34,"value":700080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.31 to $58.45 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":16850,"source":{"system":"sec-edgar","filing":"0001415889-25-024280","document":"form4-09112025_040902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925024280/form4-09112025_040902.xml","form_type":"4"}},{"id":1043219,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:30:15.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":30.86,"value":370320.0,"ownership":{"direct":true},"balance_after":28850,"source":{"system":"sec-edgar","filing":"0001415889-25-024280","document":"form4-09112025_040902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925024280/form4-09112025_040902.xml","form_type":"4"}},{"id":1084625,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T20:05:33.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represent restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."}],"balance_after":31660,"source":{"system":"sec-edgar","filing":"0001140361-25-026404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125026404/form4.xml","form_type":"4"}},{"id":1308715,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T22:20:34.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025."}],"balance_after":8800,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":8800},"source":{"system":"sec-edgar","filing":"0001415889-25-001027","document":"form4-01072025_050126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001027/form4-01072025_050126.xml","form_type":"4"}},{"id":1308714,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T22:20:34.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026."}],"balance_after":16850,"source":{"system":"sec-edgar","filing":"0001415889-25-001027","document":"form4-01072025_050126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001027/form4-01072025_050126.xml","form_type":"4"}},{"id":1472993,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:10:28.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":23944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025."}],"balance_after":23944,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":23944},"source":{"system":"sec-edgar","filing":"0001140361-24-030728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124030728/form4.xml","form_type":"4"}},{"id":1508810,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-20T20:39:51.000Z","date":"2024-05-02","kind":"gift","planned":false,"acquired":false,"shares":59716,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The David P. Southwell Irrevocable Trust Dtd 04/14/2024"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were transferred by the Reporting Person as a gift to The David P. Southwell Irrevocable Trust Dtd 04/14/2024. No funds were exchanged, and no sale of shares occurred in the transfer."}],"balance_after":113124,"source":{"system":"sec-edgar","filing":"0001140361-24-026884","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026884/form4.xml","form_type":"4"}},{"id":1508809,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-20T20:39:51.000Z","date":"2024-05-02","kind":"gift","planned":false,"acquired":false,"shares":113124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were transferred by the Reporting Person as a gift to The David P. Southwell Irrevocable Trust Dtd 04/14/2024. No funds were exchanged, and no sale of shares occurred in the transfer."}],"balance_after":1660,"source":{"system":"sec-edgar","filing":"0001140361-24-026884","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026884/form4.xml","form_type":"4"}},{"id":1521056,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T21:20:13.000Z","date":"2024-05-08","kind":"gift","planned":false,"acquired":false,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares by the Reporting Person to The David P. Southwell Irrevocable Trust of 2024 (the \"Trust\") for no consideration. The Trust has an independent trustee with investment control over the transferred shares, and the Reporting Person and members of his family are the beneficiaries of the Trust."}],"balance_after":12850,"source":{"system":"sec-edgar","filing":"0001415889-24-012891","document":"form4-05102024_050502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924012891/form4-05102024_050502.xml","form_type":"4"}},{"id":1541064,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-16T21:45:27.000Z","date":"2024-04-15","kind":"exercise","planned":false,"acquired":false,"shares":29624,"price":4.342,"value":128627.408,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option represents a right to purchase a total of 99,624 shares of the Issuer's Common Stock, which became fully vested and exercisable on January 4, 2018."}],"balance_after":0,"derivative":{"exercise_price":4.342,"expiration_date":"2024-08-28","underlying":"Common Stock","underlying_shares":29624},"source":{"system":"sec-edgar","filing":"0001140361-24-020127","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124020127/form4.xml","form_type":"4"}},{"id":1541063,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-16T21:45:27.000Z","date":"2024-04-12","kind":"exercise","planned":false,"acquired":false,"shares":70000,"price":4.342,"value":303940.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option represents a right to purchase a total of 99,624 shares of the Issuer's Common Stock, which became fully vested and exercisable on January 4, 2018."}],"balance_after":29624,"derivative":{"exercise_price":4.342,"expiration_date":"2024-08-28","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001140361-24-020127","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124020127/form4.xml","form_type":"4"}},{"id":1541062,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-16T21:45:27.000Z","date":"2024-04-15","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":24.052,"value":240520.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares were sold by the Reporting Person in order to cover certain tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.85 to $24.335. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":114784,"source":{"system":"sec-edgar","filing":"0001140361-24-020127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124020127/form4.xml","form_type":"4"}},{"id":1541061,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-16T21:45:27.000Z","date":"2024-04-15","kind":"exercise","planned":false,"acquired":true,"shares":29624,"price":4.342,"value":128627.408,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares received upon exercise of Stock Options, which would otherwise expire in August 2024."}],"balance_after":124784,"source":{"system":"sec-edgar","filing":"0001140361-24-020127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124020127/form4.xml","form_type":"4"}},{"id":1541060,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-16T21:45:27.000Z","date":"2024-04-12","kind":"sale","planned":false,"acquired":false,"shares":10284,"price":25.156,"value":258704.304,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares were sold by the Reporting Person in order to cover certain tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.155 to $25.17. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":95160,"source":{"system":"sec-edgar","filing":"0001140361-24-020127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124020127/form4.xml","form_type":"4"}},{"id":1541059,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-16T21:45:27.000Z","date":"2024-04-12","kind":"sale","planned":false,"acquired":false,"shares":59716,"price":24.224,"value":1446560.384,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares were sold by the Reporting Person in order to cover certain tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.87 to $24.68. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":105444,"source":{"system":"sec-edgar","filing":"0001140361-24-020127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124020127/form4.xml","form_type":"4"}},{"id":1541058,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-16T21:45:27.000Z","date":"2024-04-12","kind":"exercise","planned":false,"acquired":true,"shares":70000,"price":4.342,"value":303940.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares received upon exercise of Stock Options, which would otherwise expire in August 2024."}],"balance_after":165160,"source":{"system":"sec-edgar","filing":"0001140361-24-020127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124020127/form4.xml","form_type":"4"}},{"id":1639151,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T21:20:15.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024."}],"balance_after":10000,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-004121","document":"form4-02162024_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924004121/form4-02162024_040201.xml","form_type":"4"}},{"id":1639150,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-16T21:20:15.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001415889-24-004121","document":"form4-02162024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924004121/form4-02162024_040201.xml","form_type":"4"}},{"id":1844105,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T23:47:46.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":25850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024."}],"balance_after":25850,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":25850},"source":{"system":"sec-edgar","filing":"0001140361-23-031525","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123031525/form4.xml","form_type":"4"}},{"id":1917514,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-19T20:11:21.000Z","date":"2023-04-17","kind":"exercise","planned":true,"acquired":false,"shares":11429,"price":18.01,"value":205836.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":11429},"source":{"system":"sec-edgar","filing":"0001415889-23-006696","document":"form4-04192023_080416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006696/form4-04192023_080416.xml","form_type":"4"}},{"id":1917513,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-19T20:11:21.000Z","date":"2023-04-17","kind":"sale","planned":true,"acquired":false,"shares":5188,"price":51.434,"value":266839.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.01 to $51.835 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001415889-23-006696","document":"form4-04192023_080416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006696/form4-04192023_080416.xml","form_type":"4"}},{"id":1917512,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-19T20:11:21.000Z","date":"2023-04-17","kind":"sale","planned":true,"acquired":false,"shares":6241,"price":50.6886,"value":316347.5526,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":15688,"source":{"system":"sec-edgar","filing":"0001415889-23-006696","document":"form4-04192023_080416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006696/form4-04192023_080416.xml","form_type":"4"}},{"id":1917511,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-19T20:11:21.000Z","date":"2023-04-17","kind":"exercise","planned":true,"acquired":true,"shares":11429,"price":18.01,"value":205836.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."}],"balance_after":21929,"source":{"system":"sec-edgar","filing":"0001415889-23-006696","document":"form4-04192023_080416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006696/form4-04192023_080416.xml","form_type":"4"}},{"id":1929685,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T20:07:03.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":2571,"price":18.01,"value":46303.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Currently exercisable."}],"balance_after":11429,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2571},"source":{"system":"sec-edgar","filing":"0001415889-23-005991","document":"form4-04042023_080442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005991/form4-04042023_080442.xml","form_type":"4"}},{"id":1929684,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:07:03.000Z","date":"2023-03-31","kind":"sale","planned":true,"acquired":false,"shares":2571,"price":50.0476,"value":128672.3796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001415889-23-005991","document":"form4-04042023_080442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005991/form4-04042023_080442.xml","form_type":"4"}},{"id":1929683,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:07:03.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":2571,"price":18.01,"value":46303.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."}],"balance_after":13071,"source":{"system":"sec-edgar","filing":"0001415889-23-005991","document":"form4-04042023_080442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005991/form4-04042023_080442.xml","form_type":"4"}},{"id":1936020,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T20:20:33.000Z","date":"2023-03-27","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":27.05,"value":270500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.05,"expiration_date":"2024-01-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-23-005565","document":"form4-03292023_080327.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005565/form4-03292023_080327.xml","form_type":"4"}},{"id":1936019,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T20:20:33.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":100,"price":46.03,"value":4603.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001415889-23-005565","document":"form4-03292023_080327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005565/form4-03292023_080327.xml","form_type":"4"}},{"id":1936018,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T20:20:33.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":5301,"price":45.4132,"value":240735.3732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":10600,"source":{"system":"sec-edgar","filing":"0001415889-23-005565","document":"form4-03292023_080327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005565/form4-03292023_080327.xml","form_type":"4"}},{"id":1936017,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T20:20:33.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":4599,"price":44.7092,"value":205617.6108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.97 to $44.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":15901,"source":{"system":"sec-edgar","filing":"0001415889-23-005565","document":"form4-03292023_080327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005565/form4-03292023_080327.xml","form_type":"4"}},{"id":1936016,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T20:20:33.000Z","date":"2023-03-27","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":27.05,"value":270500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023."}],"balance_after":20500,"source":{"system":"sec-edgar","filing":"0001415889-23-005565","document":"form4-03292023_080327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005565/form4-03292023_080327.xml","form_type":"4"}},{"id":2030677,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-06T22:18:26.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-02-01","underlying":"Voting Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-004063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924323004063/doc4.xml","form_type":"4"}},{"id":2059216,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T21:10:22.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023."}],"balance_after":10000,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-23-000669","document":"form4-01092023_090110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000669/form4-01092023_090110.xml","form_type":"4"}},{"id":2059215,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:10:22.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 5, 2023 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 6, 2023 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 5, 2024. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001415889-23-000669","document":"form4-01092023_090110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000669/form4-01092023_090110.xml","form_type":"4"}},{"id":2201372,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-27T20:30:58.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":3.27,"expiration_date":"2032-07-24","underlying":"Voting Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-026849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322026849/doc4.xml","form_type":"4"}},{"id":2231307,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T01:07:12.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":47745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023."}],"balance_after":47745,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":47745},"source":{"system":"sec-edgar","filing":"0001140361-22-023146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122023146/form4.xml","form_type":"4"}},{"id":2261989,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Voting Common Stock","published_at":"2022-05-20T20:15:23.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":10000,"price":3.5482,"value":35482.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.45 to $3.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":171569,"source":{"system":"sec-edgar","filing":"0000899243-22-019018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322019018/doc4.xml","form_type":"4"}},{"id":2261988,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Voting Common Stock","published_at":"2022-05-20T20:15:23.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":15000,"price":3.6226,"value":54339.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.379 to $3.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":161569,"source":{"system":"sec-edgar","filing":"0000899243-22-019018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322019018/doc4.xml","form_type":"4"}},{"id":2430695,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:25:27.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":275000,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-17","underlying":"Voting Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000899243-22-002647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322002647/doc4.xml","form_type":"4"}},{"id":2438140,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2022-01-11T21:10:02.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 7, 2022 and vests over one year in twelve equal monthly installments, commencing on February 7, 2022."}],"balance_after":12000,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-22-000384","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000384/edgar.xml","form_type":"4"}},{"id":2438139,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-11T21:10:02.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 7, 2022 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 8, 2022 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 7, 2023. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001179110-22-000384","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000384/edgar.xml","form_type":"4"}},{"id":2458672,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-27T21:30:15.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":48670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares originally subject to this option vested over 4 years of service following October 9, 2018, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. In addition, all of the shares subject to this option shall vest and become fully exercisable upon a Change of Control (as defined in the option agreement)."}],"balance_after":21161,"derivative":{"exercise_price":1.97,"expiration_date":"2029-02-04","underlying":"Voting Common Stock","underlying_shares":48670},"source":{"system":"sec-edgar","filing":"0000899243-21-049764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924321049764/doc4.xml","form_type":"4"}},{"id":2458671,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Voting Common Stock","published_at":"2021-12-27T21:30:15.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":48670,"price":1.97,"value":95879.9,"ownership":{"direct":true},"balance_after":146569,"source":{"system":"sec-edgar","filing":"0000899243-21-049764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924321049764/doc4.xml","form_type":"4"}},{"id":2574863,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Voting Common Stock","published_at":"2021-09-09T20:43:38.000Z","date":"2021-09-08","kind":"purchase","acquired":true,"shares":11000,"price":8.7333,"value":96066.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $8.64 to $8.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":97899,"source":{"system":"sec-edgar","filing":"0000899243-21-035442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924321035442/doc4.xml","form_type":"4"}},{"id":2666008,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T00:01:42.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":12236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022."}],"balance_after":12236,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":12236},"source":{"system":"sec-edgar","filing":"0001140361-21-021295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121021295/form4.xml","form_type":"4"}},{"id":2912628,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2021-01-08T22:05:55.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 6, 2021 and vests over one year in twelve equal monthly installments, commencing on February 6, 2021."}],"balance_after":10000,"derivative":{"exercise_price":66.49,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-21-000460","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000460/edgar.xml","form_type":"4"}},{"id":2912627,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-08T22:05:55.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") granted on January 6, 2021 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 8, 2021 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 6, 2022. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death."}],"balance_after":3300,"source":{"system":"sec-edgar","filing":"0001179110-21-000460","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000460/edgar.xml","form_type":"4"}},{"id":3003226,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"exercise","acquired":false,"shares":12000,"price":11.23,"value":134760.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":11.23,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3003225,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"exercise","acquired":false,"shares":15000,"price":10.85,"value":162750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3003224,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":500,"price":52.178,"value":26089.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.14 to $52.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":1650,"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3003223,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":11500,"price":51.516,"value":592434.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.10 to $52.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":2150,"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3003222,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"exercise","acquired":true,"shares":12000,"price":11.23,"value":134760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020."}],"balance_after":13650,"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3003221,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":700,"price":52.183,"value":36528.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.16 to $52.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":1650,"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3003220,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":14300,"price":51.503,"value":736492.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.12 to $52.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":2350,"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3003219,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T20:34:17.000Z","date":"2020-10-16","kind":"exercise","acquired":true,"shares":15000,"price":10.85,"value":162750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020."}],"balance_after":16650,"source":{"system":"sec-edgar","filing":"0001179110-20-010602","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010602/edgar.xml","form_type":"4"}},{"id":3105284,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T01:41:16.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021."}],"balance_after":20000,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-20-014244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120014244/form4.xml","form_type":"4"}},{"id":3296970,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2020-01-31T21:41:55.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020."}],"balance_after":10000,"derivative":{"exercise_price":51.16,"expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001070081-20-000049","document":"wf-form4_158050689677166.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000049/wf-form4_158050689677166.xml","form_type":"4"}},{"id":3296969,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-31T21:41:55.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") granted on January 29, 2020 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 10, 2020 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 29, 2021. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (i) four years from the date of grant and (ii) the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death."}],"balance_after":1650,"source":{"system":"sec-edgar","filing":"0001070081-20-000049","document":"wf-form4_158050689677166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000049/wf-form4_158050689677166.xml","form_type":"4"}},{"id":3682491,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T23:55:50.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on January 28, 2020."}],"balance_after":30000,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-19-002021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119002021/form4.xml","form_type":"4"}},{"id":3688318,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-24T22:47:52.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019."}],"balance_after":14000,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-19-003200","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465919003200/a4.xml","form_type":"4"}},{"id":3730482,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-15T02:06:35.000Z","date":"2018-12-13","kind":"sale","acquired":false,"shares":38768,"price":15.19,"value":588885.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were made for the sole purpose of fulfilling the reporting person's tax obligations in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.00 to $15.80. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":95160,"source":{"system":"sec-edgar","filing":"0001140361-18-045226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118045226/form4.xml","form_type":"4"}},{"id":3737413,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-12-10T22:03:38.000Z","date":"2018-11-28","kind":"exercise","acquired":false,"shares":65625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of RCKT common stock upon satisfaction of vesting conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units were issued pursuant to the Rocket Pharmaceuticals Inc. 2014 Stock Option and Incentive Plan. The restricted stock units became fully vested on January 4, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units were issued pursuant to the Rocket Pharmaceuticals Inc. 2014 Stock Option and Incentive Plan. The restricted stock units became fully vested on January 4, 2018."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":153125},"source":{"system":"sec-edgar","filing":"0001140361-18-044850","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/form4.xml","form_type":"4"}},{"id":3737412,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-10T22:03:38.000Z","date":"2018-12-07","kind":"sale","acquired":false,"shares":4923,"price":14.91,"value":73401.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported sales were made for the sole purpose of fulfilling the reporting person's tax obligations in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $14.75 to $15.20. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":133928,"source":{"system":"sec-edgar","filing":"0001140361-18-044850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/form4.xml","form_type":"4"}},{"id":3737411,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-10T22:03:38.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":52809,"price":15.15,"value":800056.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported sales were made for the sole purpose of fulfilling the reporting person's tax obligations in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $14.91 to $15.65. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":138851,"source":{"system":"sec-edgar","filing":"0001140361-18-044850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/form4.xml","form_type":"4"}},{"id":3737410,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-10T22:03:38.000Z","date":"2018-11-28","kind":"exercise","acquired":true,"shares":153125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a right to receive one share of RCKT common stock upon satisfaction of vesting conditions."}],"balance_after":191660,"source":{"system":"sec-edgar","filing":"0001140361-18-044850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/form4.xml","form_type":"4"}},{"id":3903543,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T00:01:38.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":6073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest and become exercisable in full on June 5, 2019, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":6073,"derivative":{"exercise_price":11.54,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":6073},"source":{"system":"sec-edgar","filing":"0000899243-18-015328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924318015328/doc4.xml","form_type":"4"}},{"id":3976186,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-04-03T00:18:28.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":21875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 13,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 26,664 shares vesting in equal monthly installments over the following two years."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of RCKT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were issued pursuant to the Rocket Pharmaceuticals Inc. 2014 Stock Option and Incentive Plan. The restricted stock units vest in equal annual installments over 4 years from the January 23, 2017 date of grant, subject to continued service through such dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were issued pursuant to the Rocket Pharmaceuticals Inc. 2014 Stock Option and Incentive Plan. The restricted stock units vest in equal annual installments over 4 years from the January 23, 2017 date of grant, subject to continued service through such dates."}],"balance_after":65625,"derivative":{"underlying":"Common Stock","underlying_shares":21875},"source":{"system":"sec-edgar","filing":"0000899243-18-009127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924318009127/doc4.xml","form_type":"4"}},{"id":3976185,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-03T00:18:28.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 13,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 26,664 shares vesting in equal monthly installments over the following two years."}],"balance_after":40000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-18-009127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924318009127/doc4.xml","form_type":"4"}},{"id":3976184,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T00:18:28.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":21875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of RCKT common stock."}],"balance_after":38535,"source":{"system":"sec-edgar","filing":"0000899243-18-009127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924318009127/doc4.xml","form_type":"4"}},{"id":3978801,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-30T21:30:28.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":12146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in thirty-six equal monthly installments at the end of each successive month following March 30, 2018, subject to the Reporting Person's continued service as a director through the applicable vesting dates."}],"balance_after":12146,"derivative":{"exercise_price":14.25,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":12146},"source":{"system":"sec-edgar","filing":"0000899243-18-008989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924318008989/doc4.xml","form_type":"4"}},{"id":4105896,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2018-01-05T21:15:35.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018."}],"balance_after":14000,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001070081-18-000022","document":"wf-form4_151518692149812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008118000022/wf-form4_151518692149812.xml","form_type":"4"}},{"id":4482886,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-01-24T21:31:24.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ITEK common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were issued pursuant to the Plan. The restricted stock units shall vest in equal annual installments over 4 years from the date of grant, subject to continued service through such dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were issued pursuant to the Plan. The restricted stock units shall vest in equal annual installments over 4 years from the date of grant, subject to continued service through such dates."}],"balance_after":350000,"derivative":{"underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000899243-17-001845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924317001845/doc4.xml","form_type":"4"}},{"id":4482885,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-01-24T21:31:24.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ITEK common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan (the \"Plan\") on December 13, 2016 and were amended on January 23, 2017 to modify their vesting schedule. The restricted stock units were modified so that instead of vesting based on the achievement of certain milestones, they will vest in equal annual installments over four years from the December 13, 2016 date of grant, subject to continued service through such dates.  The amount in this column does not reflect the decrease in fair value as a result of the modification to the restricted stock units in 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan (the \"Plan\") on December 13, 2016 and were amended on January 23, 2017 to modify their vesting schedule. The restricted stock units were modified so that instead of vesting based on the achievement of certain milestones, they will vest in equal annual installments over four years from the December 13, 2016 date of grant, subject to continued service through such dates.  The amount in this column does not reflect the decrease in fair value as a result of the modification to the restricted stock units in 2017."}],"balance_after":350000,"derivative":{"underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000899243-17-001845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924317001845/doc4.xml","form_type":"4"}},{"id":4495007,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-09T22:54:21.000Z","date":"2017-01-06","kind":"purchase","acquired":true,"shares":60000,"price":1.75,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.749 to $1.75, inclusive. The reporting person undertakes to provide to Inotek Pharmaceuticals Corporation, any security holder of Inotek Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,765 shares of the Issuer's common stock acquired under the Issuer's Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 with Table I Information."}],"balance_after":62765,"source":{"system":"sec-edgar","filing":"0000899243-17-000861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924317000861/doc4.xml","form_type":"4"}},{"id":4495390,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":26195,"kind":"person","name":"SOUTHWELL DAVID P","position":1,"cik":"0001251553","reported_name":"SOUTHWELL DAVID P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2017-01-09T22:39:14.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017."}],"balance_after":12000,"derivative":{"exercise_price":11.23,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001070081-17-000049","document":"wf-form4_148400154187189.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000049/wf-form4_148400154187189.xml","form_type":"4"}}]}